AS

ASKA Pharmaceutical Holdings CO., Ltd.

Specializes in hormone-related pharmaceuticals for internal medicine, OB/GYN, and urology.

4886 | T

Overview

Corporate Details

ISIN(s):
JP3119660003
LEI:
Country:
Japan
Address:
港区芝浦二丁目5番1号

Description

ASKA Pharmaceutical Holdings Co., Ltd. is a healthcare group engaged in the research, development, manufacturing, and sale of pharmaceuticals. The company specializes in hormone-related medicines, with a primary focus on three therapeutic areas: internal medicine, obstetrics and gynecology, and urology. It is a leading provider of treatments for thyroid disease. The product portfolio includes various hormone preparations, such as the emergency contraceptive pill NORLEVO® and leuprorelin acetate for injection, used in treating conditions like prostate cancer and endometriosis. The group actively pursues the creation of innovative products, including new antibody drugs, through research and development collaborations to meet evolving medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 07:10
確認書
Japanese 8.2 KB
2025-11-07 07:09
半期報告書-第5期(2025/04/01-2026/03/31)
Japanese 195.0 KB
2025-06-27 08:15
臨時報告書
Japanese 31.4 KB
2025-06-20 08:11
確認書
Japanese 8.2 KB
2025-06-20 08:10
内部統制報告書-第4期(2024/04/01-2025/03/31)
Japanese 28.7 KB
2025-06-20 08:08
有価証券報告書-第4期(2024/04/01-2025/03/31)
Japanese 1.4 MB
2025-02-07 07:41
臨時報告書
Japanese 21.4 KB
2024-11-08 07:04
確認書
Japanese 8.1 KB
2024-11-08 07:02
半期報告書-第4期(2024/04/01-2025/03/31)
Japanese 183.3 KB
2024-06-28 07:12
臨時報告書
Japanese 22.0 KB
2024-06-25 06:40
確認書
Japanese 8.2 KB
2024-06-25 06:39
内部統制報告書-第3期(2023/04/01-2024/03/31)
Japanese 23.6 KB
2024-06-25 06:37
有価証券報告書-第3期(2023/04/01-2024/03/31)
Japanese 1.3 MB
2024-02-09 07:07
確認書
Japanese 8.1 KB
2024-02-09 07:05
四半期報告書-第3期第3四半期(2023/10/01-2023/12/31)
Japanese 155.2 KB

Automate Your Workflow. Get a real-time feed of all ASKA Pharmaceutical Holdings CO., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ASKA Pharmaceutical Holdings CO., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ASKA Pharmaceutical Holdings CO., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.